Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
NFL
U.S.
2024 Election
Local
World
Science
Technology
AI
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Semaglutide, Novo Nordisk
Novo Nordisk CEO Warns of Deaths Linked to Compounded Semaglutide
THURSDAY, Nov. 7, 2024 (HealthDay News) -- The head of the company that makes the diabetes and obesity drugs Ozempic and Wegovy has warned that compounded versions of the active ingredient in those medications have now been linked to at least 100 hospitalizations and 10 deaths.
Semaglutide Compounding Safety Concerns: 10 Deaths Reported
Novo Nordisk’s CEO has alerted healthcare professionals about the growing risks associated with compounded semaglutide, a medication linked to at least 10 deaths in the U.S. Learn more about the safety concerns.
Compounded semaglutide associated with at least 10 deaths, Novo Nordisk CEO warns
Compounded versions of semaglutide, the active ingredient in approved diabetes and obesity drugs Ozempic and Wegovy, have been associated with at least 100 hospitalizations and 10 deaths, the chief executive of Ozempic maker Novo Nordisk warned Wednesday.
Novo Nordisk says it is aware of 10 deaths from compounded weight-loss drug copies
Novo Nordisk is aware of 100 hospitalizations and 10 deaths resulting from people taking compounded copies of its popular weight-loss and diabetes drugs, the drugmaker's finance chief said on Wednesday.
Hosted on MSN
1d
CGM OK'd During Medical Imaging; All Semaglutide Doses Back; Bariatric Surgery Down
The position was supported by the TRAVERSE trial findings. (Mayo Clinic Proceedings) All doses of
semaglutide
(Ozempic, ...
7d
7 common myths about semaglutide and weight loss debunked
Wegovy® is the only version of semaglutide that is FDA-approved for weight loss, while Ozempic® and other forms of the drug ...
The American Journal of Managed Care
21h
Semaglutide Linked to Reduced Health Care Expenses for Patients With Obesity, HF, ASCVD
Results demonstrated the mean total medical costs per patient per year decreased significantly after patients began ...
STAT
6d
The semaglutide drought may be ending
Ozempic and Wegovy, made by Novo Nordisk, are now listed as available across all doses on the FDA’s drug shortage list. But ...
Rolling Out
4d
7 exciting ways to reduce Alzheimer’s risk with semaglutide
For years, scientists have observed a connection between type 2 diabetes and an increased risk of dementia, particularly ...
Renal & Urology News
1d
Semaglutide Improves Liver Fibrosis With MASH Resolution
Topline results were announced from a phase 3 clinical trial evaluating subcutaneous semaglutide in patients with MASH and liver fibrosis.
KSL
3d
Don't want the side effects of the shots? Best alternative to Semaglutide and other drugs
Dr. Whit Roberts of Health Utah says he is concerned about the financial costs and health risks potentially posed by popular ...
Endocrinology Advisor
1d
Semaglutide Reduces Knee Osteoarthritis Pain in Adults With Obesity
Topline results were announced from a phase 3 clinical trial evaluating subcutaneous semaglutide in obesity and knee osteoarthritis.
10d
Does Compounded Semaglutide Work for Weight Loss?
Compounded semaglutide can be an affordable alternative to brand-name weight loss injections like Ozempic and Wegovy. But ...
Futurism on MSN
5d
Semaglutide So Effective at Treating Arthritis That Patients Were “More or Less Were Treated Out of the Study”
In a groundbreaking new study, the active ingredient in Ozempic was found to be so effective at treating arthritis that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Related topics
Ozempic
Novo Nordisk
Wegovy
ESSENCE trial
MASH
Feedback